Fig. 1From: Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocolStudy design and timeline of events for participants with Binge Eating Disorder (BED) and healthy controlsBack to article page